Principles for Feeling Great Now and Learning How To Live To Be 100
In this webinar for the Broken Science Initiative Medical Society, Dr. Libby Wilson shares her journey from conventional family medicine to functional medicine, emphasizing a shift from treating symptoms to identifying root causes of illness.
Dr. Wilson outlines her four-phase approach to healing: addressing adrenal health, restoring gut balance, supporting mitochondrial function, and optimizing hormones. She stresses that the body is inherently designed to feel well, and when it doesn’t, there is always a reason—one that often lies in overlooked lifestyle and physiological factors. Her care philosophy centers on removing what harms the body and replacing what it needs, using data-driven protocols, natural therapies, and a strong emphasis on lifestyle—especially stress, sleep, and nutrition. Through compelling patient stories and lab results, she demonstrates that chronic symptoms and even autoimmune conditions like Hashimoto’s can be reversed with consistent, root-cause-based care.
After practicing as a board-certified family physician for 15 years, Dr. Wilson became disillusioned with the limitations of the insurance-based, symptom-focused model. Driven by personal and family health challenges, she pursued certification through the Institute for Functional Medicine and launched her own cash-based, virtual practice—Best Life Functional Medicine—which now serves clients across the U.S. and internationally.
This BSI Medical Society Webinar was streamed on March 12th, 2025.
A 10-minute summary of the webinar is available here free, for anyone, while the full webinar is available for Medical Society Members in their dashboard.
Let's start with the truth!
Support the Broken Science Initiative.
Subscribe today →
recent posts
Metabolic health, medical education, and the case for bringing clinicians and coaches together
At the 2026 Unbreakable Health Retreat in Miami, Emily Kaplan hosted a panel with Bob Kaplan, Professor Thomas Seyfried, and Dr. Derek Lee on what it means to treat cancer as a metabolic disease. They discussed the glucose-ketone index (GKI), nutritional ketosis, and strategies aimed at restricting the fuels cancer cells depend on while considering how metabolic therapy can fit alongside standard cancer treatment.
The conversation also addressed the practical realities patients face when trying to pursue a metabolic approach within the conventional oncology system, including questions about nutrition, repurposed drugs, inherited cancer risk, and how to evaluate different treatment options. Seyfried and Lee connected these clinical questions back to mitochondrial dysfunction, fermentation, and the metabolic vulnerabilities that may offer additional targets for cancer treatment.
An abbreviated version of this discussion is available here, for free.
At the 2026 Unbreakable Health Retreat in Miami, Professor Thomas Seyfried presented the case that cancer is fundamentally a mitochondrial metabolic disease rather than primarily a genetic one. He contrasts the dominant somatic mutation theory with a metabolic model in which impaired mitochondrial respiration drives a shift toward fermentation, dysregulated cell growth, and the mutations commonly associated with cancer.
Citing the work of Otto Warburg and research from his lab at Boston College, Seyfried explains how cancer cells rely heavily on fermentable fuels—particularly glucose and glutamine—and why mitochondrial dysfunction sits upstream of many of the genetic abnormalities seen in tumors. He also discusses reactive oxygen species, altered cellular signaling, and the role of mitochondria in regulating cell growth and behavior.
The presentation then turns to the therapeutic implications of this model. Seyfried explains strategies aimed at placing tumor cells under metabolic stress by restricting the fuels they depend on, including ketogenic metabolic therapy and approaches targeting glucose and glutamine. For Seyfried, the therapeutic target follows directly from the biology: restrict the fuels cancer cells depend on, exploit their metabolic weaknesses, and treat mitochondrial dysfunction as the central feature of the disease.
An abbreviated version of this discussion is available here, for free.
MetFix and BSI Members can view the full 54-minute video.
